BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6481186)

  • 21. Characterization of clinical and environmental types of Vibrio vulnificus isolates from Louisiana oysters.
    Han F; Pu S; Hou A; Ge B
    Foodborne Pathog Dis; 2009 Dec; 6(10):1251-8. PubMed ID: 19743928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of iron in the virulence of Vibrio vulnificus isolated from Cuddalore coastal waters (India).
    Jayalakshmi S; Venugopalan VK
    Indian J Med Res; 1992 Nov; 95():294-6. PubMed ID: 1291464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of Vibrio vulnificus isolated from cockles and patients in Thailand.
    Mala W; Chomvarin C; Alam M; Rashed SM; Faksri K; Angkititrakul S
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):103-12. PubMed ID: 24964659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uridinediphosphogalactose-4-epimerase deficiency in Salmonella typhimurium and its correction by plasmoid-borne galactose genes of Escherichia coli K-12: effects on mouse virulence, phagocytosis, and serum sensitivity.
    Krishnapillai V
    Infect Immun; 1971 Sep; 4(3):177-88. PubMed ID: 4949486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Vibrio vulnificus by indirect immunofluorescence.
    Gray LD; Kreger AS
    Diagn Microbiol Infect Dis; 1985 Nov; 3(6):461-8. PubMed ID: 3905226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of Vibrio vulnificus.
    Linkous DA; Oliver JD
    FEMS Microbiol Lett; 1999 May; 174(2):207-14. PubMed ID: 10339810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species.
    Tamplin ML; Specter S; Rodrick GE; Friedman H
    Infect Immun; 1983 Dec; 42(3):1187-90. PubMed ID: 6642665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.
    Simon GL; Klempner MS; Kasper DL; Gorbach SL
    J Infect Dis; 1982 Jan; 145(1):72-7. PubMed ID: 7054319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of a marker plasmid to examine differential rates of growth and death between clinical and environmental strains of Vibrio vulnificus in experimentally infected mice.
    Starks AM; Bourdage KL; Thiaville PC; Gulig PA
    Mol Microbiol; 2006 Jul; 61(2):310-23. PubMed ID: 16856938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the lipopolysaccharide of a virulent and an avirulent strain of Vibrio vulnificus.
    Bahrani K; Oliver JD
    Biochem Cell Biol; 1990 Feb; 68(2):547-51. PubMed ID: 1693085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the virulence plasmid pR99 and the metalloprotease Vvp in resistance of Vibrio vulnificus serovar E to eel innate immunity.
    Valiente E; Lee CT; Lamas J; Hor L; Amaro C
    Fish Shellfish Immunol; 2008 Jan; 24(1):134-41. PubMed ID: 18053741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vibrio Vulnificus infections can be avoided.
    Bisharat N
    Isr Med Assoc J; 2002 Aug; 4(8):631-3. PubMed ID: 12183871
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety and vaccine efficacy of an attenuated Vibrio vulnificus strain with deletions in major cytotoxin genes.
    Kim YR; Lee SE; Kim JR; Rhee JH
    FEMS Microbiol Lett; 2015 Dec; 362(23):fnv169. PubMed ID: 26381905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice.
    Wright AC; Morris JG
    Infect Immun; 1991 Jan; 59(1):192-7. PubMed ID: 1846124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virulence properties of Vibrio vulnificus isolated from diseased zoea of freshness shrimp Macrobrachium rosenbergii.
    Li X; Zhou Y; Jiang Q; Yang H; Pi D; Liu X; Gao X; Chen N; Zhang X
    Microb Pathog; 2019 Feb; 127():166-171. PubMed ID: 30521845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and efficacy of an attenuated Vibrio harveyi vaccine candidate with cross protectivity against Vibrio alginolyticus.
    Hu YH; Deng T; Sun BG; Sun L
    Fish Shellfish Immunol; 2012 Jun; 32(6):1155-61. PubMed ID: 22484605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological effects of the lipopolysaccharide of Vibrio vulnificus on mice and rats.
    McPherson VL; Watts JA; Simpson LM; Oliver JD
    Microbios; 1991; 67(272-273):141-9. PubMed ID: 1779875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RTX toxin enhances the survival of Vibrio vulnificus during infection by protecting the organism from phagocytosis.
    Lo HR; Lin JH; Chen YH; Chen CL; Shao CP; Lai YC; Hor LI
    J Infect Dis; 2011 Jun; 203(12):1866-74. PubMed ID: 21422475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiplex PCR for detection of virulence markers of Vibrio vulnificus.
    Bier N; Diescher S; Strauch E
    Lett Appl Microbiol; 2015 May; 60(5):414-20. PubMed ID: 25604517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A conserved GTPase YchF of Vibrio vulnificus is involved in macrophage cytotoxicity, iron acquisition, and mouse virulence.
    Chen YC; Chung YT
    Int J Med Microbiol; 2011 Aug; 301(6):469-74. PubMed ID: 21570909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.